CD8A and hepatocellular carcinoma: Given RIN1 could still be present in the supernatant and directly affect CD8+ T cells one way or another and could promote T cell activation by itself, we compared the effects of DMSO, RIN1, HCCDMSO-sup and HCCRIN1-sup on patient HCC infiltrating CD8+ T cells.